Cohen Haim Y, Lavu Siva, Bitterman Kevin J, Hekking Brian, Imahiyerobo Thomas A, Miller Christine, Frye Roy, Ploegh Hidde, Kessler Benedikt M, Sinclair David A
Department of Pathology, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115 USA.
Mol Cell. 2004 Mar 12;13(5):627-38. doi: 10.1016/s1097-2765(04)00094-2.
Apoptosis is a key tumor suppression mechanism that can be initiated by activation of the proapoptotic factor Bax. The Ku70 DNA end-joining protein has recently been shown to suppress apoptosis by sequestering Bax from mitochondria. The mechanism by which Bax is regulated remains unknown. Here, we identify eight lysines in Ku70 that are targets for acetylation in vivo. Five of these, K539, K542, K544, K533, and K556, lie in the C-terminal linker domain of Ku70 adjacent to the Bax interaction domain. We show that CBP and PCAF efficiently acetylate K542 in vitro and associate with Ku70 in vivo. Mimicking acetylation of K539 or K542 or treating cells with deacetylase inhibitors abolishes the ability of Ku70 to suppress Bax-mediated apoptosis. We demonstrate that increased acetylation of Ku70 disrupts the Ku70-Bax interaction and coincides with cytoplasmic accumulation of CBP. These results shed light on the role of acetyltransferases as tumor suppressors.
细胞凋亡是一种关键的肿瘤抑制机制,可由促凋亡因子Bax的激活引发。Ku70 DNA末端连接蛋白最近被证明可通过将Bax隔离在线粒体之外来抑制细胞凋亡。Bax的调控机制仍然未知。在这里,我们鉴定出Ku70中的八个赖氨酸是体内乙酰化的靶点。其中五个,即K539、K542、K544、K533和K556,位于Ku70与Bax相互作用结构域相邻的C末端连接结构域中。我们表明,CBP和PCAF在体外可有效乙酰化K542,并在体内与Ku70相关联。模拟K539或K542的乙酰化或用去乙酰化酶抑制剂处理细胞会消除Ku70抑制Bax介导的细胞凋亡的能力。我们证明,Ku70乙酰化增加会破坏Ku70与Bax的相互作用,并与CBP的细胞质积累同时发生。这些结果揭示了乙酰转移酶作为肿瘤抑制因子的作用。